Published in Infect Immun on August 01, 1988
Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80
Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76
The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect Immun (1989) 1.63
The number of direct repeats in hagA is variable among Porphyromonas gingivalis strains. Infect Immun (1998) 0.94
Strategies in the development of vaccines to prevent infections with group A streptococcus. Hum Vaccin Immunother (2013) 0.80
The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice. J Infect Dis (2010) 0.79
A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Anal Biochem (1981) 15.38
Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor. J Biol Chem (1986) 6.38
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
M proteins of group A streptococci. Bacteriol Rev (1974) 3.15
Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84
Antigenic variation among group A streptococcal M proteins. Nucleotide sequence of the serotype 5 M protein gene and its relationship with genes encoding types 6 and 24 M proteins. J Biol Chem (1988) 2.61
Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med (1985) 2.61
Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med (1985) 2.53
The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem (1984) 2.40
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J Bacteriol (1988) 1.86
Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65
Common protective antigens of group A streptococcal M proteins masked by fibrinogen. J Exp Med (1984) 1.59
Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J Immunol (1986) 1.54
Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog (1987) 1.51
Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies. Infect Immun (1984) 1.43
Cloning and genetic analysis of serotype 5 M protein determinant of group A streptococci: evidence for multiple copies of the M5 determinant in the Streptococcus pyogenes genome. Infect Immun (1985) 1.37
Expression of protective and cardiac tissue cross-reactive epitopes of type 5 streptococcal M protein in Escherichia coli. Infect Immun (1985) 1.07
Homologous and heterologous protection of mice with group A streptococcal M protein vaccines. Infect Immun (1977) 0.91
Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis (1981) 14.19
Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol (1985) 10.22
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97
Heterogeneity of tetracycline resistance determinants in Streptococcus. J Bacteriol (1982) 6.20
Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99
Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55
Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med (1975) 5.30
Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40
Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J Infect Dis (1974) 4.15
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage. Infect Immun (1978) 3.47
Streptococcal tetracycline resistance mediated at the level of protein synthesis. J Bacteriol (1986) 3.46
Identification of tetracycline-resistant R-plasmids in Streptococcus agalactiae (group B). Antimicrob Agents Chemother (1980) 3.40
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol Microbiol (1994) 3.14
Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11
The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J Bacteriol (1986) 2.93
Nomenclature for new tetracycline resistance determinants. Antimicrob Agents Chemother (1999) 2.89
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun (1983) 2.85
Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84
Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med (1985) 2.61
Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus. Infect Immun (1985) 2.60
Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59
Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med (1985) 2.53
Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun (1983) 2.48
Nomenclature for tetracycline resistance determinants. Antimicrob Agents Chemother (1989) 2.46
Transfer of plasmids by conjugation in Streptococcus pneumonias. Plasmid (1980) 2.44
Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest (1978) 2.40
Binding of group A streptococci to human oral mucosal cells by lipoteichoic acid. Trans Assoc Am Physicians (1975) 2.32
Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol (1987) 2.26
Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol (1969) 2.25
Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (1988) 2.24
Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol (1982) 2.22
Horizontal gene transfer in the evolution of group A streptococcal emm-like genes: gene mosaics and variation in Vir regulons. Mol Microbiol (1994) 2.21
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19
Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18
Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells. Infect Immun (1977) 2.17
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin. J Clin Invest (1979) 2.10
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J Exp Med (1980) 2.00
Induction of delayed hypersensitivity to influenza and mumps viruses in mice. J Immunol (1969) 1.99
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. J Exp Med (1983) 1.96
Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera. Infect Immun (1984) 1.95
Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial. J Clin Microbiol (1996) 1.91
Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J Bacteriol (1988) 1.86
Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J Exp Med (1983) 1.82
Bacterial adherence. Adv Intern Med (1980) 1.80
Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77
Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J Biol Chem (1980) 1.75
Redundant exonuclease involvement in Escherichia coli methyl-directed mismatch repair. J Biol Chem (2001) 1.75
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74
Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun (1974) 1.74
Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol (1973) 1.73
Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrob Agents Chemother (1987) 1.72
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol (1975) 1.72
Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun (1985) 1.71
Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med (1986) 1.71
Superantigenicity of streptococcal M protein. J Exp Med (1990) 1.70
Structural organization of a 67-kilobase streptococcal conjugative element mediating multiple antibiotic resistance. J Bacteriol (1985) 1.68
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Hydrophobic interactions of group A streptococci with hexadecane droplets. J Bacteriol (1983) 1.67
Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis (1980) 1.67
Erythrocyte binding properties of streptococcal lipoteichoic acids. Infect Immun (1979) 1.65
Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65
Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med (1988) 1.63
Binding of streptococcal lipoteichoic acid to fatty acid-binding sites on human plasma fibronectin. J Bacteriol (1983) 1.63
Enzyme-linked immunosorbent assay for adherence of bacteria to animal cells. J Clin Microbiol (1986) 1.62
Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect Immun (2000) 1.60
Common protective antigens of group A streptococcal M proteins masked by fibrinogen. J Exp Med (1984) 1.59
Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J Exp Med (1982) 1.59
Binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun (1986) 1.58
Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J Immunol (1986) 1.54
Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med (1982) 1.53
Interaction of human plasma fibronectin with cariogenic and non-cariogenic oral streptococci. Infect Immun (1983) 1.53
The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man. Trans Assoc Am Physicians (1972) 1.51
Postnatal development of binding of streptococci and lipoteichoic acid by oral mucosal cells of humans. J Infect Dis (1977) 1.50
Influence of sublethal concentrations of antibiotics on the expression of the mannose-specific ligand of Escherichia coli. Infect Immun (1980) 1.49
Lymphocytes binding and T cell mitogenic properties of group A streptococcal lipoteichoic acid. J Immunol (1979) 1.49
Comparison of the leader sequences of four group A streptococcal M protein genes. Nucleic Acids Res (1988) 1.44
Hyperadhesive mutant of type 1-fimbriated Escherichia coli associated with formation of FimH organelles (fimbriosomes). Infect Immun (1988) 1.44
Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies. Infect Immun (1984) 1.43
Sequence of myosin-crossreactive epitopes of streptococcal M protein. J Exp Med (1986) 1.43
Characterization of lipoteichoic acid binding to polymorphonuclear leukocytes of human blood. Infect Immun (1981) 1.43
Role of fibronectin in attachment of Streptococcus pyogenes and Escherichia coli to human cell lines and isolated oral epithelial cells. Infect Immun (1985) 1.41
Cloning and genetic analysis of serotype 5 M protein determinant of group A streptococci: evidence for multiple copies of the M5 determinant in the Streptococcus pyogenes genome. Infect Immun (1985) 1.37
Rabbit corneal damage produced by Pseudomonas aeruginosa infection. Infect Immun (1975) 1.36
Mouse skin damage caused by cytolysin from Vibrio vulnificus and by V. vulnificus infection. J Infect Dis (1987) 1.34
Isolation and characterization of a receptor for type 1 fimbriae of Escherichia coli from guinea pig erythrocytes. J Biol Chem (1988) 1.34